Comparison of Efficacy and Safety of Different Doses of Nifekalant Instant Cardioversion of Persistent Atrial Fibrillation During Radiofrequency Ablation
NCT04209959
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Atrial Fibrillation
Interventions
DRUG:
nifekalant
Sponsor
Second Affiliated Hospital of Nanchang University